Cancer metabolism is based on alterations of metabolic activities compared to normal cells, one of the most observed metabolic alterations in several cancers is the increased uptake of glucose to support growth by energy production and the formation of precursors such as nucleotides, amino acids, and lipids. The primary experience of the researcher is in biochemistry, genetics, and metabolism, more specifically, in the characterization of carbon source metabolism.

Tumour progression requires a metabolic rewiring of cancer cells, providing enough energy for metabolism and cellular growth and increasing cancer cells' fitness for proliferation and survival. The Researcher is working on carbohydrate metabolism supporting brain tumour progression and signalling pathways responsible for meningioma development, the most common brain tumours, classified by the World Health Organization (WHO) according to aggressiveness and recurrence as grade 1, 2 atypical, and 3 anaplastic. 

Dr Alistair J. P. Brown, MRC Centre for Medical Mycology, University of Exeter, UK.
Dr Neil Andrew Brown, Department of Biology & Biochemistry, University of Bath, UK.
Dr Thomas Kruger, Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology, Germany.
Dr Gerhard H. Braus, Microbiology, and Genetics, Gottingen, Georg-August-University of Gottingen, Germany.
Dr Bayram Ozgur, Fungal Genetics and Secondary Metabolism Laboratory, Department of Biology, Maynooth University, Ireland.
Dr Daysuke Hogawara, Medical Mycology Research Centre (MMRC), Chiba University, Japan.
Dr Gustavo H. Goldman, Molecular Biology, Ribeirão Preto, São Paulo, University of São Paulo, Brazil.

Review editor, Cancer Metabolism: Frontiers in Oncology

Journal reviewer:

mBio

Biotechnology for Biofuels  

Spectrum Microbiology

Fungal Genetics and Biology

Applied and Environmental Microbiology